Drug delivery across the blood-brain barrier: Recent advances in the use of nanocarriers

John Je Mulvihill, Eoghan M. Cunnane, Aisling M. Ross, Jason T. Duskey, Giovanni Tosi, Andreas M. Grabrucker

Research output: Contribution to journalArticlepeer-review

Abstract

The blood-brain barrier (BBB) has a significant contribution to homeostasis and protection of the CNS. However, it also limits the crossing of therapeutics and thereby complicates the treatment of CNS disorders. To overcome this limitation, the use of nanocarriers for drug delivery across the BBB has recently been exploited. Nanocarriers can utilize different physiological mechanisms for drug delivery across the BBB and can be modified to achieve the desired kinetics and efficacy. Consequentially, several nanocarriers have been reported to act as functional nanomedicines in preclinical studies using animal models for human diseases. Given the rapid development of novel nanocarriers, this review provides a comprehensive insight into the most recent advancements made in nanocarrier-based drug delivery to the CNS, such as the development of multifunctional nanomedicines and theranostics.

Original languageEnglish
Pages (from-to)205-214
Number of pages10
JournalNanomedicine
Volume15
Issue number2
DOIs
Publication statusPublished - 2020

Keywords

  • BBB
  • PLGA
  • brain
  • drug targeting
  • exosomes
  • liposomes nano
  • nanomedicines
  • nanoparticles
  • theranostics

Fingerprint

Dive into the research topics of 'Drug delivery across the blood-brain barrier: Recent advances in the use of nanocarriers'. Together they form a unique fingerprint.

Cite this